Photo of Cecilia Stahlhut

Counsel, Mexico City

Cecilia Stahlhut Espinosa represents life sciences and consumer products companies in Mexico, with a focus on health and consumer law matters. She works with clients throughout all stages of complex and innovative projects. Her years of experience as external counsel to many life sciences companies offer her unique insight into the industry.

She has a wealth of experience in regulatory drug matters (pharmaceutical), medical devices and equipment, research and development, biotechnology, compliance of new product technologies, and general health regulatory compliance. Cecilia has particular experience in the regulation of cosmetics, food, alcohol, tobacco, and consumer products in Mexico.

She has also participated in the planning and adoption of regulatory strategies for various companies, with respect to product advertising and labeling, product liability, marketing of high-tech products, and the launching of new products. She also advises clients on sophisticated regulatory structures and the restructuring of business models and operations, clinical research projects, approval and marketing authorization pathways, standards for regulated products, and challenging labeling and advertising issues.

Cecilia has reviewed promotional materials for an extensive range of products and advised clients on promotional activities and compliance of regulations regarding interactions with health care professionals and related organizations.

Recently, Cecilia was seconded to a major orphan drug company to advise on regulatory framework applicable to orphan drugs as well as the ongoing business activities of the client, including contracts, advertising, marketing, pharmacovigilance, and health-corporate governance.

On July 31st 2020, the Interinstitutional Accord between the Ministry of Economy and the Ministry of Health, through the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and the Consumer Protection Federal Bureau (PROFECO) regarding the surveillance activities of the Amendment to the Modification of the Mexican Official Standard NOM-051-SCFI/SSA1-2010, was published on

The amendment to the General Health Law concerning overweight, obesity, and Front Labeling Warnings for prepackaged food and non-alcoholic beverages will become into force, as per its publication in the Official Federal Gazette (FOG) on November 8, 2019.

The referred amendment main purpose is to establish new provisions and guidelines regarding those legends, pictograms and

On October 10, 2019, the Draft Amendment to the Mexican Official Standard NOM-051-SCFI/SSA1-2010, General Labelling Specifications for Prepackaged Foods and Non-Alcoholic Beverages-Commercial and Health Information (NOM-051) was published in the Federal Official Gazette (DOF).

The aforementioned publication derives from the amendment process which is subject to the referred Mexican Official Standard. As part

On October 7th, 2019, the Regulatory Impact Analysis and the draft amendment of the Official Mexican Standard NOM-051-SCFI/SSA1-2010 – “General Labelling Specifications for Pre-packaged Foods and Non-Alcoholic Beverages – Commercial and Health Information” were published in the portal of the National Commission on Regulatory Improvement. The foregoing was the result of the proposal

On July 24, 2019, the Health Commission of the Chamber of Deputies approved the draft opinion that amends and adds various provisions to the General Health Law concerning overweight, obesity, and front labeling of food and non-alcoholic beverages.

The approved amendments to the General Health Law have, as its main purpose, the right to health